COVID-19: Expert Review of Relevant and Emerging Literature

COVID-19: Expert Reviews of Relevant and Emerging Literature2020-08-07T11:15:25-04:00
Published on :  | By Maria Brann

Review: Academy of Communication in Healthcare communication tools

The COVID-19 communication tools from the Academy of Communication in Healthcare offers health providers simple strategies for more effective communication.

In this article, a chief health officer argues that communication about COVID-19 must be immediate and transparent.

This is a rapid sentinel surveillance study aimed to determine what proportion of mild, outpatient influenza-like illnesses were caused by SARS-CoV-2.

This community-based surveillance study reports a 5% rate of COVID-19 among patients presented to the ED or urgent care with mild influenza-like illness.

This opinion piece in the New England Journal of Medicine emphasizes a need for a coordinated approach by local and national government, the private sector, and health care providers to attain needed personal protective equipment (PPE) and ventilators.

The authors suggest:

In a mixed methods study, researchers found that effective crisis leaders provide information updates and emotional coping advice.

During crises, people look to government for guidance, protection, and stability. Effective government crisis communication leaders exhibit the following competencies: crisis perceptiveness, humility, flexibility, presence, and cooperation. Keeping people safe and informed is of utmost importance. Communicatively, leaders must provide coping advice, uncertainty management and explanations, and gratitude during crisis.

Published on :  | By Daniel Orenstein

Review: FDA authorizes emergency use of unproven drugs to treat coronavirus

FDA will allow distribution of large quantities of two anti-malarial drugs from the federal Strategic National Stockpile to hospitals as a possible treatment for COVID-19, using the agency’s authority to permit use of unapproved medical products or unapproved uses of approved medical products during an emergency.

Published on :  | By Seema Mohapatra

Review: U.S. ICU resource availability for COVID-19

The Society of Critical Care Medicine (SCCM) has updated its statistics on critical care resources available in the United States in light of the onset of COVID-19 and the strong possibility of large percentages of the U.S. population being admitted to the hospital and intensive care unit (ICU).

This study investigated the case fatality rate (CFR) among confirmed COVID-19 cases (N=22,512) in Italy, using Italian National Institute of Health surveillance data up to March 17, 2020.

In this small sample of COVID-19 infected patients who were mostly young, male with mild infections, half were viral positive even after resolution of their symptoms. This information can provide useful tool for clinicians and policymakers to ensure that recovered patients do not spread the virus.

This document presents estimates of predicted health service utilization and deaths due to COVID-19 by day for the next 4 months for each state in the US.

This study provides useful information about when we can expect antibodies to appear after infection, and how that might be used in future clinical testing.

We are still learning about the antibody response in patients infected with COVID-19 This is a case series of 173 patients with SARS-CoV-2. Serial plasma samples (n=535) were collected during the hospitalizations, and they tested for total antibodies (Ab), IgM and IgG.

Published on :  | By Maria Brann

Review: COVID-19: Are we getting the communications right?

In an editorial, UK’s government was criticized for being slow to respond to the pandemic by not following instructive experiences from other countries.

In this preliminary uncontrolled case series of 5 critically ill patients with COVID-19 and ARDS, convalescent plasma containing neutralizing antibody showed promising results in treating severe cases. These observations require evaluation in clinical trials.

We would really like to have a treatment for COVID-19. This preliminary study sought to determine whether a plasma transfusion from recovered patients may help critically ill patients with severe infections.

The authors describe a case series of 5 critically ill patients with laboratory-confirmed COVID-19 and acute respiratory distress syndrome (ARDS) who had:

This report details why cruises are at significant risk for outbreaks, and no one should be going on one during the COVID-19 pandemic.

About 30 million people travel on 272 cruise ships each year worldwide. Cruise ships are a closed environment where travelers from many countries come into contact with each other. Because of that, they are often the setting for outbreaks. This report details more than 800 cases of lab-confirmed cased of COVID-19 from three cruise ship voyages. Other cruises have detailed smaller outbreaks. Ten associated deaths have been reported so far.

This study explains why long-term care facilities are at high risk for Covid-19 outbreaks and must identify and exclude potentially infected staff and visitors, actively monitor for potentially infected patients, and implement appropriate infection prevention and control measures.

On February 28, 2020, after a confirmed case of Covid-19 was identified, the authors launched a case investigation, contact tracing, quarantine of exposed persons, isolation of confirmed and suspected cases, and on-site enhancement of infection prevention and control. This report details their findings.

This study comparing patients who died from COVID to those who recovered details some laboratory values that are more/less common as well as the most common complications.

This study compared the clinical characteristics of 113 patients who died from COVID to 161 who recovered in China. Key findings included:

Published on :  | By Ross Silverman

Review: Arrests made for COVID-19 violations in Florida, Illinois

Local law enforcement in Florida and Illinois have arrested individuals for endangering others during the outbreak.

Daily Digest Links
Creative Commons License The literature reviews on this blog were created under a Creative Commons Attribution-NonCommercial 4.0 International License , which allows the reuse and adaptation of the work by noncommercial entities. These rights do not extend to the articles that the authors are reviewing.
  • This field is for validation purposes and should be left unchanged.

Get Involved with Indiana CTSI